• FNPs for Stable Lung-Directed mRNA Delivery

  2026-08-17

  The reference study introduces five-element nanoparticles (FNPs) that combine poly(β-amino esters) with DOTAP to improve lung-directed mRNA delivery and formulation stability. Its structure–activity analysis and lyophilization results suggest a practical route toward storage-stable extrahepatic delivery systems, while also defining important limits for translating reporter-mRNA performance into therapeutic conclusions.

• Acridine Orange hydrochloride: Practical Guide

  2026-08-16

  Acridine Orange hydrochloride provides a practical fluorescent readout for nucleic-acid content, with green and red emission patterns that can support DNA/RNA differential staining, cell cycle analysis, apoptosis detection, and flow cytofluorometric workflows. It should be used as a nucleic-acid staining reagent with freshly prepared solutions, not as a stand-alone proof of apoptosis or as a long-term stored solution.

• From CBS Biology to Translational Mouse Genotyping

  2026-08-15

  A mechanistic study of host-derived CBS in Staphylococcus aureus udder infection illustrates why dependable mouse genotyping is a strategic foundation for translational research. This article connects barrier biology, experimental validation, and scalable tissue-to-PCR workflows.

• SB 202190: A p38–Cell-Death Decision Framework

  2026-08-15

  SB 202190 is a selective p38 MAP kinase inhibitor for dissecting how stress signaling intersects with apoptosis and necroptosis. This guide translates RIPK1 phosphoregulation findings into practical assay design for inflammation research, cancer therapeutics research, and neurobiology models.

• AIBP–LRP2–HDL Axis in Collateral Circulation

  2026-08-14

  The reference study identifies an AIBP–LRP2–HDL–miR-223 pathway that restrains the expansion of CXCR4-positive, stemlike capillary endothelial cells during collateral vessel formation. Its combination of patient profiling, ischemic mouse models, genetic perturbation, and mechanistic testing suggests that restoring CXCR4 activity could improve revascularization, although clinical translation remains to be established.

• α2-AR Agonists in Osteosarcoma Recurrence

  2026-08-14

  The reference study investigates local delivery of the α2-adrenergic receptor agonist UK14,304 after osteosarcoma resection, showing reduced recurrence in immunocompetent mice without substantial direct effects on tumor-cell viability, migration, or invasion in vitro. Proteomic and bioinformatic analyses connect the response to CD8+ T-cell activity, T-cell receptor signaling, ITGAL-centered regulation, and possible liquid-liquid phase separation.

• ALDH2 Activation Delays Heart Failure in Mice

  2026-08-13

  A 2025 Experimental Cell Research study identifies ALDH2 as a regulator of cardiomyocyte proliferative capacity, not only as a mitochondrial enzyme involved in aldehyde metabolism. Pharmacological ALDH2 activation extended the early postnatal proliferative window and delayed pressure overload-induced heart failure in adult mice, suggesting a regenerative strategy that requires further validation.

• CUDC-907 Protocol and QC Guidance

  2026-08-13

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle progression, and apoptosis. This guidance uses the product dossier rather than directly matched paper evidence and is intended for research workflows only, not diagnostic, clinical, or therapeutic use.

• Sitagliptin phosphate monohydrate in Gut Metabolism

  2026-08-12

  Sitagliptin phosphate monohydrate provides a controlled DPP-4 inhibitor arm for separating incretin hormone modulation from intestinal stretch signaling. This workflow combines target engagement, active GLP-1 and GIP measurements, oral glucose tolerance, feeding behavior, and nucleus of the solitary tract readouts to strengthen mechanistic metabolic studies.

• Norepinephrine Formulation Reporting in Critical Care

  2026-08-12

  This position paper identifies a major reproducibility and patient-safety problem: norepinephrine doses are not always reported according to a consistent chemical basis. Its joint SCCM–ESICM guidance recommends global use of a norepinephrine-base formulation or explicit base-equivalent reporting to improve dose calculation, trial interpretation, and cross-country data comparability.

• Arrb2, 6-ketoLCA, and Hepatic IRI

  2026-08-11

  A 2026 Hepatology Communications study identifies a hepatocyte–macrophage–metabolite axis in hepatic ischemia–reperfusion injury. The work links hepatocyte Arrb2 with increased 6-ketoLCA, M2 macrophage polarization, and improved injury outcomes across clinical, mouse, and hypoxia–reoxygenation models.

• Miltefosine for Neutrophil Differentiation Assays

  2026-08-10

  Miltefosine is a versatile pathway-modulating tool for studying neutrophil differentiation, leukopenia recovery, and PI3K/Akt-dependent signaling. This workflow-oriented guide connects the compound’s established Akt phosphorylation inhibition profile with newer Ras/MEK/ERK findings and provides practical optimization and troubleshooting strategies.

• Sanggenol L Drives Ferroptosis in NSCLC via miRNA

  2026-08-09

  The reference study identifies sanggenol L as an inducer of ferroptosis in non-small cell lung cancer and maps its activity to the miR-26a-1-3p/MDM2/p53/SLC7A11 axis. By combining cellular ferroptosis readouts, genetic pathway analysis, xenografts, and patient-derived tumor models, the work provides a mechanistic basis for evaluating this natural product as a preclinical anticancer candidate.

• (-)-Norepinephrine (+)-bitartrate in Cardiovascular Models

  2026-08-08

  (-)-Norepinephrine (+)-bitartrate supports both controlled adrenergic receptor assays and physiologically relevant cardiovascular model development. This guide connects fresh-solution handling, concentration-response design, receptor-affinity measurements, and troubleshooting for more reproducible blood pressure and heart rate studies.

• Alda 1: Translational Leverage for ALDH2 Biology

  2026-08-07

  Alda 1 offers a mechanistically focused way to investigate ALDH2 activity, reactive aldehyde handling, cardioprotection in ischemia, and radiation-induced dermatitis mitigation. By connecting enzyme activation with cardiomyocyte proliferation and tissue resilience, this perspective outlines how translational researchers can move beyond descriptive antioxidant biology toward genotype-aware, pathway-based study design.

455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page